Cargando…

The development of gene-based vectors for immunization

Mostrar otras versiones (2)

Detalles Bibliográficos
Autor principal:	Nabel, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310921/ http://dx.doi.org/10.1016/B978-1-4160-3611-1.50066-0

Ejemplares similares

The development of gene-based vectors for immunization
por: Weiner, David B., et al.
Publicado: (2013)

Development of Gene-Based Vectors for Immunization
por: Weiner, David B., et al.
Publicado: (2018)

Genetic, cellular and immune approaches to disease therapy: past and future
por: Nabel, Gary J
Publicado: (2004)

P17-27. Development of recombinant adenovirus 28 vectors for HIV vaccines
por: Ko, S, et al.
Publicado: (2009)

P19-37. Replication-defective lymphocytic choriomeningitis virus vectors boost cellular and humoral immunity after DNA or adenovirus vector priming
por: Flatz, LR, et al.
Publicado: (2009)

Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
por: Koup, Richard A., et al.
Publicado: (2010)

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
por: Sullivan, Nancy J., et al.
Publicado: (2009)

Characterization of human adenovirus 35 and derivation of complex vectors
por: McVey, Duncan, et al.
Publicado: (2010)

Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006)

A multiclade DNA/Ad vaccines for AIDS: the present and next generation
por: Nabel, Gary J
Publicado: (2006)

Emerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
por: von Jonquieres, Georg, et al.
Publicado: (2021)

Immune Activities of Polycationic Vectors for Gene Delivery
por: Zhao, Xiaotian, et al.
Publicado: (2017)

Immune Responses to Viral Gene Therapy Vectors
por: Shirley, Jamie L., et al.
Publicado: (2020)

Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant
por: Rady, Hamada F., et al.
Publicado: (2016)

The Protein Kinase KIS Impacts Gene Expression during Development and Fear Conditioning in Adult Mice
por: Manceau, Valérie, et al.
Publicado: (2012)

A gene-based avian influenza vaccine in poultry
por: Rao, S.S., et al.
Publicado: (2009)

Innate Immune Response to Viral Vectors in Gene Therapy
por: Wang, Yixuan, et al.
Publicado: (2023)

Modulation of immune responses in lentiviral vector-mediated gene transfer
por: Annoni, Andrea, et al.
Publicado: (2019)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

Development of lentiviral vectors for gene therapy of arthritis
por: Militello, M, et al.
Publicado: (2001)

Development of Viral Vectors for Use in Cardiovascular Gene Therapy
por: Williams, Paul D., et al.
Publicado: (2010)

Coronavirus Reverse Genetics and Development of Vectors for Gene Expression
por: Enjuanes, L., et al.
Publicado: (2005)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Development of Viral Vectors for Gene Therapy for Chronic Pain
por: Huang, Yu, et al.
Publicado: (2011)

Developments in Viral Vector-Based Vaccines
por: Ura, Takehiro, et al.
Publicado: (2014)

Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023)

The Development of Functional Non-Viral Vectors for Gene Delivery
por: Patil, Suryaji, et al.
Publicado: (2019)

Immunopathology of highly virulent pathogens: insights from Ebola virus
por: Zampieri, Carisa A, et al.
Publicado: (2007)

Development of an Expression Vector to Overexpress or Downregulate Genes in Curvularia protuberata
por: Liu, Chengke, et al.
Publicado: (2018)

Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy
por: Mulia, Grace Elizabeth, et al.
Publicado: (2021)

Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
por: Shoti, Jakob, et al.
Publicado: (2022)

Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells
por: Cheng, Cheng, et al.
Publicado: (2007)

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
por: Aldhamen, Yasser Ali, et al.
Publicado: (2011)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Vaccine Development in the Twenty‐First Century: Changing Paradigms for Elusive Viruses
por: Graham, B S, et al.
Publicado: (2009)

Optimized conditions for gene transduction into primary immune cells using viral vectors
por: Kim, Yeongrin, et al.
Publicado: (2023)

Siberian Development Vector: Based on Cooperation and Interaction
por: Kryukov, V. A., et al.
Publicado: (2020)

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014)

Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
por: Mingozzi, F, et al.
Publicado: (2013)

Viral Vector-Based Melanoma Gene Therapy
por: Hromic-Jahjefendic, Altijana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ldu9no59ark558ktpm042kddor